Analytical Data
-
Gene name
TNMD
- Application
-
Alternative Names
TNMD;CHM1L;Tenomodulin
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H2S6
-
Expression Region
1-317aa
-
AA Sequence
MAKNPPENCEDCHILNAEAFKSKKICKSLKICGLVFGILALTLIVLFWGSKHFWPEVPKKAYDMEHTFYSNGEKKKIYMEIDPVTRTEIFRSGNGTDETLEVHDFKNGYTGIYFVGLQKCFIKTQIKVIPEFSEPEEEIDENEEITTTFFEQSVIWVPAEKPIENRDFLKNSKILEICDNVTMYWINPTLISVSELQDFEEEGEDLHFPANEKKGIEQNEQWVVPQVKVEKTRHARQASEEELPINDYTENGIEFDPMLDERGYCCIYCRRGNRYCRRVCEPLLGYYPYPYCYQGGRVICRVIMPCNWWVARMLGRV
-
Molecular Weight
37.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TNMD (Tenomodulin) is an intriguing protein that has garnered interest for its role in tendon biology and regenerative medicine. It is primarily expressed in tendons and ligaments, where it plays a crucial role in their development, maintenance, and healing processes. Research into TNMD has highlighted its potential involvement in modulating cellular activities, such as promoting tenocyte proliferation and regulating extracellular matrix composition. Due to its unique expression pattern and functions, TNMD is being investigated as a potential therapeutic target for treating tendon injuries and other musculoskeletal disorders. Studies have shown that TNMD can influence the healing environment by promoting a favorable tissue response and enhancing the repair process. Furthermore, recombinant TNMD proteins are being explored for their applications in tissue engineering and regenerative therapies, aiming to improve tendon healing and restore function. The exploration of TNMD's properties, its interactions with other signaling pathways, and its implications in therapeutic contexts represents a significant advancement in understanding tendon biology and developing innovative treatments for tendon-related injuries. As research progresses, a deeper comprehension of TNMD's mechanisms may lead to breakthroughs in regenerative medicine and the enhancement of recovery in individuals suffering from tendon injuries.











